Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Nyström A[au]:

The role of TGFβ in wound healing pathologies. Kiritsi D et al. Mech Ageing Dev. (2018)

RNA-based therapies for genodermatoses. Bornert O et al. Exp Dermatol. (2017)

Cell therapy for basement membrane-linked diseases. Nyström A et al. Matrix Biol. (2017)

Search results

Items: 1 to 50 of 211

1.

Secondary glaucoma and visual outcome after paediatric cataract surgery with primary bag-in-the-lens intraocular lens.

Nyström A, Magnusson G, Zetterberg M.

Acta Ophthalmol. 2019 Sep 11. doi: 10.1111/aos.14244. [Epub ahead of print]

PMID:
31509341
2.

Reversion for correction: fibroblasts to the rescue!

Nyström A, Kiritsi D.

Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18318. [Epub ahead of print] No abstract available.

PMID:
31361326
3.

Intraocular lens implantation in children with cataract.

Hildebrand GD, Tassignon MJ, Vasavada AR, Nischal KK, Nyström A.

Lancet Child Adolesc Health. 2019 Jul;3(7):e6-e7. doi: 10.1016/S2352-4642(19)30151-8. No abstract available.

PMID:
31178029
4.

Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders.

Spörrer M, Prochnicki A, Tölle RC, Nyström A, Esser PR, Homberg M, Athanasiou I, Zingkou E, Schilling A, Gerum R, Thievessen I, Winter L, Bruckner-Tuderman L, Fabry B, Magin TM, Dengjel J, Schröder R, Kiritsi D.

EBioMedicine. 2019 Jun;44:502-515. doi: 10.1016/j.ebiom.2019.04.062. Epub 2019 May 9.

5.

Cloning and Mutagenesis Strategies for Large Collagens.

Bornert O, Nyström A.

Methods Mol Biol. 2019;1944:3-15. doi: 10.1007/978-1-4939-9095-5_1.

PMID:
30840231
6.

Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.

Nyström A, Mörse H, Nordlöf H, Wiebe K, Artman M, Øra I, Giwercman A, Henic E, Elfving M.

Acta Oncol. 2019 Feb;58(2):218-224. doi: 10.1080/0284186X.2018.1529423. Epub 2018 Dec 18.

PMID:
30558460
7.

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.

Oria VO, Lopatta P, Schmitz T, Preca BT, Nyström A, Conrad C, Bartsch JW, Kulemann B, Hoeppner J, Maurer J, Bronsert P, Schilling O.

Mol Oncol. 2019 Feb;13(2):456-479. doi: 10.1002/1878-0261.12426. Epub 2019 Jan 9.

8.

Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa.

Cianfarani F, De Domenico E, Nyström A, Mastroeni S, Abeni D, Baldini E, Ulisse S, Uva P, Bruckner-Tuderman L, Zambruno G, Castiglia D, Odorisio T.

Matrix Biol. 2019 Aug;81:3-16. doi: 10.1016/j.matbio.2018.12.001. Epub 2018 Dec 5.

PMID:
30528862
9.

Matrix molecules and skin biology.

Nyström A, Bruckner-Tuderman L.

Semin Cell Dev Biol. 2019 May;89:136-146. doi: 10.1016/j.semcdb.2018.07.025. Epub 2018 Aug 4. Review.

PMID:
30076963
10.

Balance and circumstance: The renin angiotensin system in wound healing and fibrosis.

Bernasconi R, Nyström A.

Cell Signal. 2018 Nov;51:34-46. doi: 10.1016/j.cellsig.2018.07.011. Epub 2018 Jul 30. Review.

PMID:
30071289
11.

Recent advances in understanding and managing epidermolysis bullosa.

Kiritsi D, Nyström A.

F1000Res. 2018 Jul 17;7. pii: F1000 Faculty Rev-1097. doi: 10.12688/f1000research.14974.1. eCollection 2018. Review.

12.

Precision Mass Measurements of Neutron-Rich Neodymium and Samarium Isotopes and Their Role in Understanding Rare-Earth Peak Formation.

Orford R, Vassh N, Clark JA, McLaughlin GC, Mumpower MR, Savard G, Surman R, Aprahamian A, Buchinger F, Burkey MT, Gorelov DA, Hirsh TY, Klimes JW, Morgan GE, Nystrom A, Sharma KS.

Phys Rev Lett. 2018 Jun 29;120(26):262702. doi: 10.1103/PhysRevLett.120.262702.

PMID:
30004776
13.

Collagen VII deficient mice show morphologic and histologic corneal changes that phenotypically mimic human dystrophic epidermolysis bullosa of the eye.

Chen VM, Shelke R, Nyström A, Laver N, Sampson JF, Zhiyi C, Bhat N, Panjwani N.

Exp Eye Res. 2018 Oct;175:133-141. doi: 10.1016/j.exer.2018.06.008. Epub 2018 Jun 18.

PMID:
29920270
14.

Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization.

Nguyen DT, O'Hara M, Graneli C, Hicks R, Miliotis T, Nyström AC, Hansson S, Davidsson P, Gan LM, Magnone MC, Althage M, Heydarkhan-Hagvall S.

Sci Rep. 2018 May 10;8(1):7458. doi: 10.1038/s41598-018-25883-x.

15.

A Dynamic Model of Resource Allocation in Response to the Presence of a Synthetic Construct.

Nyström A, Papachristodoulou A, Angel A.

ACS Synth Biol. 2018 May 18;7(5):1201-1210. doi: 10.1021/acssynbio.8b00015. Epub 2018 May 10.

PMID:
29745649
16.

Svag evidens för rehabkoordinatorer.

Hedman F, Hansson L, Engström S, Liljedahl A, Svärd JO, Jacks J, Nyström A, Malvezzi M.

Lakartidningen. 2018 May 3;115. pii: E6TP. Swedish. No abstract available.

17.

Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone.

Has C, Nyström A, Saeidian AH, Bruckner-Tuderman L, Uitto J.

Matrix Biol. 2018 Oct;71-72:313-329. doi: 10.1016/j.matbio.2018.04.001. Epub 2018 Apr 5. Review.

PMID:
29627521
18.

Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa.

Nyström A, Bruckner-Tuderman L.

Matrix Biol. 2018 Aug;68-69:547-560. doi: 10.1016/j.matbio.2018.01.016. Epub 2018 Jan 31. Review.

PMID:
29391280
19.

Phacoemulsification and primary implantation with bag-in-the-lens intraocular lens in children with unilateral and bilateral cataract.

Nyström A, Almarzouki N, Magnusson G, Zetterberg M.

Acta Ophthalmol. 2018 Jun;96(4):364-370. doi: 10.1111/aos.13626. Epub 2018 Jan 19.

20.

Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes.

Thriene K, Grüning BA, Bornert O, Erxleben A, Leppert J, Athanasiou I, Weber E, Kiritsi D, Nyström A, Reinheckel T, Backofen R, Has C, Bruckner-Tuderman L, Dengjel J.

Mol Cell Proteomics. 2018 Apr;17(4):565-579. doi: 10.1074/mcp.RA117.000437. Epub 2018 Jan 11.

21.

Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.

Nyström A, Bornert O, Kühl T, Gretzmeier C, Thriene K, Dengjel J, Pfister-Wartha A, Kiritsi D, Bruckner-Tuderman L.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E705-E714. doi: 10.1073/pnas.1709111115. Epub 2018 Jan 5.

22.

Therapies for genetic extracellular matrix diseases of the skin.

Nyström A, Bernasconi R, Bornert O.

Matrix Biol. 2018 Oct;71-72:330-347. doi: 10.1016/j.matbio.2017.12.010. Epub 2017 Dec 21. Review.

PMID:
29274938
23.

Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases.

Lacroix M, Tessier A, Dumestre-Pérard C, Vadon-Le Goff S, Gout E, Bruckner-Tuderman L, Kiritsi D, Nyström A, Ricard-Blum S, Moali C, Hulmes DJS, Thielens NM.

Sci Rep. 2017 Dec 5;7(1):16958. doi: 10.1038/s41598-017-17318-w.

24.

The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1.

Sundström L, Myhre S, Sundqvist M, Ahnmark A, McCoull W, Raubo P, Groombridge SD, Polla M, Nyström AC, Kristensson L, Någård M, Winzell MS.

PLoS One. 2017 Dec 5;12(12):e0189060. doi: 10.1371/journal.pone.0189060. eCollection 2017.

25.

Large Deletions Targeting the Triple-Helical Domain of Collagen VII Lead to Mild Acral Dominant Dystrophic Epidermolysis Bullosa.

Chmel N, Bornert O, Hausser I, Grüninger G, Borozkin W, Kohlhase J, Nyström A, Has C.

J Invest Dermatol. 2018 Apr;138(4):987-991. doi: 10.1016/j.jid.2017.11.014. Epub 2017 Nov 24. No abstract available.

26.

Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.

Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, Kern JS.

Matrix Biol. 2018 Mar;66:1-21. doi: 10.1016/j.matbio.2017.11.004. Epub 2017 Nov 20.

PMID:
29158163
27.

The role of TGFβ in wound healing pathologies.

Kiritsi D, Nyström A.

Mech Ageing Dev. 2018 Jun;172:51-58. doi: 10.1016/j.mad.2017.11.004. Epub 2017 Nov 11. Review.

PMID:
29132871
28.

The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.

Jansson AM, Csiszar A, Maier J, Nyström AC, Ax E, Johansson P, Schiavone LH.

J Biol Chem. 2017 Sep 15;292(37):15501-15511. doi: 10.1074/jbc.M117.782904. Epub 2017 Jul 27.

29.

The Paediatric Cataract Register (PECARE): an overview of operated childhood cataract in Sweden and Denmark.

Magnusson G, Haargaard B, Basit S, Lundvall A, Nyström A, Rosensvärd A, Tornqvist K.

Acta Ophthalmol. 2018 Feb;96(1):51-55. doi: 10.1111/aos.13497. Epub 2017 Jun 14.

30.

Gene Therapy for Epidermolysis Bullosa: Sticky Business.

Nyström A, Bruckner-Tuderman L.

Mol Ther. 2016 Dec;24(12):2035-2036. doi: 10.1038/mt.2016.199. No abstract available.

31.

Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa.

Bremer J, Bornert O, Nyström A, Gostynski A, Jonkman MF, Aartsma-Rus A, van den Akker PC, Pasmooij AM.

Mol Ther Nucleic Acids. 2016 Oct 18;5(10):e379. doi: 10.1038/mtna.2016.87.

32.

Cell therapy for basement membrane-linked diseases.

Nyström A, Bornert O, Kühl T.

Matrix Biol. 2017 Jan;57-58:124-139. doi: 10.1016/j.matbio.2016.07.012. Epub 2016 Sep 5. Review.

PMID:
27609402
33.

Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies.

Randall K, Henderson N, Reens J, Eckersley S, Nyström AC, South MC, Balendran CA, Böttcher G, Hughes G, Price SA.

PLoS One. 2016 Sep 6;11(9):e0162076. doi: 10.1371/journal.pone.0162076. eCollection 2016.

34.

RNA-based therapies for genodermatoses.

Bornert O, Peking P, Bremer J, Koller U, van den Akker PC, Aartsma-Rus A, Pasmooij AM, Murauer EM, Nyström A.

Exp Dermatol. 2017 Jan;26(1):3-10. doi: 10.1111/exd.13141. Review.

35.

Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.

Bornert O, Kühl T, Bremer J, van den Akker PC, Pasmooij AM, Nyström A.

Mol Ther. 2016 Aug;24(7):1302-11. doi: 10.1038/mt.2016.92. Epub 2016 May 9.

36.

Generation of a Functional Non-Shedding Collagen XVII Mouse Model: Relevance of Collagen XVII Shedding in Wound Healing.

Jacków J, Schlosser A, Sormunen R, Nyström A, Sitaru C, Tasanen K, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 Feb;136(2):516-525. doi: 10.1016/j.jid.2015.10.060. Epub 2015 Nov 18.

37.

NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

Friberg S, Nyström AM.

J Nanobiotechnology. 2016 Mar 9;14:17. doi: 10.1186/s12951-016-0172-2. Review.

38.

A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.

Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E, Nyström A, Lener T, Reichelt J, Bauer JW, Murauer EM.

Mol Ther Nucleic Acids. 2016 Mar 1;5:e287. doi: 10.1038/mtna.2016.3.

39.

Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses.

Kühl T, Mezger M, Hausser I, Guey LT, Handgretinger R, Bruckner-Tuderman L, Nyström A.

J Invest Dermatol. 2016 Jun;136(6):1116-1123. doi: 10.1016/j.jid.2016.02.002. Epub 2016 Feb 18.

40.

Collagen XVII Shedding Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR Signaling.

Jacków J, Löffek S, Nyström A, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 May;136(5):1031-1041. doi: 10.1016/j.jid.2016.01.012. Epub 2016 Jan 28.

41.

One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery.

Zheng H, Zhang Y, Liu L, Wan W, Guo P, Nyström AM, Zou X.

J Am Chem Soc. 2016 Jan 27;138(3):962-8. doi: 10.1021/jacs.5b11720. Epub 2016 Jan 12.

PMID:
26710234
42.

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L.

Cancer Res. 2016 Feb 15;76(4):940-51. doi: 10.1158/0008-5472.CAN-15-1348. Epub 2015 Dec 16.

43.

Cancer Metastases: Early Dissemination and Late Recurrences.

Friberg S, Nyström A.

Cancer Growth Metastasis. 2015 Nov 29;8:43-9. doi: 10.4137/CGM.S31244. eCollection 2015. Review.

44.

Epidermal Basement Membrane in Health and Disease.

Has C, Nyström A.

Curr Top Membr. 2015;76:117-70. doi: 10.1016/bs.ctm.2015.05.003. Epub 2015 Jun 19. Review.

PMID:
26610913
45.

Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research.

Feliu N, Pelaz B, Zhang Q, Del Pino P, Nyström A, Parak WJ.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 May;8(3):479-92. doi: 10.1002/wnan.1378. Epub 2015 Nov 21. Review.

PMID:
26589577
46.

Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Zhang Y, Lundberg P, Diether M, Porsch C, Janson C, Lynd NA, Ducani C, Malkoch M, Malmström E, Hawker CJ, Nyström AM.

J Mater Chem B. 2015 Mar 28;3(12):2472-2486.

47.

Disulfide-Functionalized Unimolecular Micelles as Selective Redox-Responsive Nanocarriers.

Porsch C, Zhang Y, Montañez MI, Malho JM, Kostiainen MA, Nyström AM, Malmström E.

Biomacromolecules. 2015 Sep 14;16(9):2872-83. doi: 10.1021/acs.biomac.5b00809. Epub 2015 Aug 11.

PMID:
26200248
48.

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L.

EMBO Mol Med. 2015 Sep;7(9):1211-28. doi: 10.15252/emmm.201505061.

49.

Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.

Friberg S, Nyström AM.

Future Oncol. 2015;11(13):1961-75. doi: 10.2217/fon.15.91.

50.

High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.

Kühl T, Mezger M, Hausser I, Handgretinger R, Bruckner-Tuderman L, Nyström A.

Mol Ther. 2015 Aug;23(8):1368-1379. doi: 10.1038/mt.2015.58. Epub 2015 Apr 10.

Supplemental Content

Loading ...
Support Center